Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies

NCT01263899 is registered in ClinicalTrials.gov with S*BIO as lead sponsor.

NCT NCT01263899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01263899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Safety and Efficacy Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies
Lead sponsor
S*BIO
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2010
Completion date
February 29, 2012
Enrollment
28 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hodgkin lymphoma, indolent lymphoma, mantle cell lymphoma